ATANASOVA, Velina S, Crhistian de Jesus CARDONA, Václav HEJRET, Andreas TIEFENBACHER, Theresia MAIR, Loan TRAN, Janette PFNEISSL, Kristina DRAGANIC, Carina BINDER, Julijan KABILJO, Janik CLEMENT, Katharina WOERAN, Barbara NEUDERT, Sabrina WOHLHAUPTER, Astrid HAASE, Sandra DOMAZET, Markus HENGSTSCHLAEGER, Markus MITTERHAUSER, Leonhard MUELLAUER, Boris TICHÝ, Michael BERGMANN, Gabriele SCHWEIKERT, Markus HARTL, Helmut DOLZNIG and Gerda EGGER. Mimicking Tumor Cell Heterogeneity of Colorectal Cancer in a Patient-derived Organoid-Fibroblast Model. CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. UNITED STATES: ELSEVIER INC, 2023, vol. 15, No 6, p. 1391-1419. ISSN 2352-345X. Available from: https://dx.doi.org/10.1016/j.jcmgh.2023.02.014.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Mimicking Tumor Cell Heterogeneity of Colorectal Cancer in a Patient-derived Organoid-Fibroblast Model
Authors ATANASOVA, Velina S, Crhistian de Jesus CARDONA, Václav HEJRET (203 Czech Republic, belonging to the institution), Andreas TIEFENBACHER, Theresia MAIR, Loan TRAN, Janette PFNEISSL, Kristina DRAGANIC, Carina BINDER, Julijan KABILJO, Janik CLEMENT, Katharina WOERAN, Barbara NEUDERT, Sabrina WOHLHAUPTER, Astrid HAASE, Sandra DOMAZET, Markus HENGSTSCHLAEGER, Markus MITTERHAUSER, Leonhard MUELLAUER, Boris TICHÝ (203 Czech Republic, belonging to the institution), Michael BERGMANN, Gabriele SCHWEIKERT, Markus HARTL, Helmut DOLZNIG and Gerda EGGER (guarantor).
Edition CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, UNITED STATES, ELSEVIER INC, 2023, 2352-345X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30219 Gastroenterology and hepatology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 7.200 in 2022
RIV identification code RIV/00216224:14740/23:00133185
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1016/j.jcmgh.2023.02.014
UT WoS 001030618700001
Keywords in English Colorectal Cancer; Fibroblasts; Organoids; targeted therapy
Tags CF GEN, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Eva Dubská, učo 77638. Changed: 8/4/2024 09:34.
Abstract
BACKGROUND & AIMS: Patient-derived organoid cancer models are generated from epithelial tumor cells and reflect tumor characteristics. However, they lack the complexity of the tumor microenvironment, which is a key driver of tumorigenesis and therapy response. Here, we developed a colorectal cancer organoid model that incorporates matched epithelial cells and stromal fibroblasts. METHODS: Primary fibroblasts and tumor cells were isolated from colorectal cancer specimens. Fibroblasts were character-ized for their proteome, secretome, and gene expression sig-natures. Fibroblast/organoid co-cultures were analyzed by immunohistochemistry and compared with their tissue of origin, as well as on gene expression levels compared with standard organoid models. Bioinformatics deconvolution was used to calculate cellular proportions of cell subsets in orga-noids based on single-cell RNA sequencing data. RESULTS: Normal primary fibroblasts, isolated from tumor adjacent tissue, and cancer associated fibroblasts retained their molecular characteristics in vitro, including higher motility of cancer associated compared with normal fibroblasts. Impor-tantly, both cancer-associated fibroblasts and normal fibro-blasts supported cancer cell proliferation in 3D co-cultures, without the addition of classical niche factors. Organoids grown together with fibroblasts displayed a larger cellular heteroge-neity of tumor cells compared with mono-cultures and closely resembled the in vivo tumor morphology. Additionally, we observed a mutual crosstalk between tumor cells and fibro-blasts in the co-cultures. This was manifested by considerably deregulated pathways such as cell-cell communication and extracellular matrix remodeling in the organoids. Thrombospondin-1 was identified as a critical factor for fibro-blast invasiveness. CONCLUSION: We developed a physiological tumor/stroma model, which will be vital as a personalized tumor model to study disease mechanisms and therapy response in colorectal cancer. (Cell Mol Gastroenterol Hepatol 2023;15:1391-1419; https://doi.org/10.1016/j.jcmgh.2023.02.014)
Links
90267, large research infrastructuresName: NCMG III
PrintDisplayed: 28/7/2024 05:23